Literature DB >> 227207

Urinary excretion of calcium, hydroxyproline and 3',5'-cyclic adenosine monophosphate in primary hyperparathyroidism.

J Halse, J O Gordeladze.   

Abstract

Urinary excretion of calcium (Ca), hydroxyproline (Hyp) and 3',5'-cyclic adenosine monophosphate (cAMP) was measured during fasting, and in the afternoon, over a 3 day period. Twelve hyperparathyroid patients, of whom 6 were re-studied after successful parathyroid surgery, and 10 control subjects participated, and were maintained on a collagen free diet for the duration of the study. Expressed as creatinine ratio values, Hyp was significantly higher in the morning than during the afternoon, whereas the Ca excretion pattern showed low morning and high afternoon values for all groups. cAMP excretion did not change during the two sampling periods. Large day to day variations for each parameter were observed in the individual patient. The value of cAMP measurements in the diagnosis of primary hyperparathyroidism was confirmed. The results may imply that a diurnal variation in Hyp excretion exists in primary hyperparathyroidism and that food intake produces a suppression of Hyp excretion, possibly secondary to suppression of parathyroid function or, in our view, to increased calcitonin excretion.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 227207     DOI: 10.1530/acta.0.0920138

Source DB:  PubMed          Journal:  Acta Endocrinol (Copenh)        ISSN: 0001-5598


  2 in total

1.  Acute effects of removal of parathyroid adenoma on plasma and urinary hydroxyproline levels.

Authors:  S Minisola; C Medori; R Antonelli; A Scarpiello; C Valtorta; S Tabolli; A Scarda; G Aliberti; E D'Erasmo; G F Mazzuoli
Journal:  J Endocrinol Invest       Date:  1984-12       Impact factor: 4.256

2.  Hydroxyproline excretion in schoolchildren and its relationship to measures of indoor air pollution.

Authors:  A J Verplanke; B Remijn; F Hoek; D Houthuijs; B Brunekreef; J S Boleij
Journal:  Int Arch Occup Environ Health       Date:  1987       Impact factor: 3.015

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.